AXNX Axonics Accounting Capitalization

Corporate emblem and logo of axonics.com (AXNX)

The price trend for Axonics, Inc. (AXNX) on GURU.Markets is 0.00, while the business relies on sourcing precision components from external partners while maintaining final assembly. High margins on urological systems and an upcoming integration with a major player strengthen its market position. Stability of clinic supplies is guaranteed by delegating assembly and global logistics to contract manufacturers.

Axonics Inc. (AXNX) - Company Book Value from 07/04/2022 to 10/27/2026

Financial and market metric breakdowns for Axonics (AXNX)

- price and consensus price forecast:
Share Price Axonics, Inc|AXNX - Consensus Target
- market capitalization data:
Market Capitalization Axonics Inc.|AXNX - Total Company Value
- book capitalization data:
Net Assets per Share Axonics|AXNX - Company Book Value|Market Capitalization to Net Assets axonics.com|AXNX - Company Total Assets
- debt and liquidity data:
Debt to Capital Axonics, Inc.|AXNX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Axonics Inc.|AXNX - Company Aggregate Debts|Debts to Net Assets Axonics Inc.
Summary company analytics:AXNX - Axonics, Inc
Mass-produced product of Axonics Modulation Technologies

The stability of electronics supplies and implant logistics for Axonics, Inc. (AXNX) directly impacts the rate of net asset accumulation minus liabilities. This balance sheet valuation of the company's capital allows investors to filter out market noise by measuring the real value of the business's own assets. Analyzing the upward trend of this metric helps determine the issuer's fundamental stability, eliminating the risk of overpaying for inflated quotes.

Competitor analysis for Axonics, Inc.

Boston Scientific Corporation Inc. (BSX) - Accounting Capitalization|Company Net Assets Edwards Lifesciences|RMD (resmed.com) - Accounting Capitalization|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|OFIX - Net Asset Value|Book Capitalization BVS|OrthoPediatrics (KIDS) - Total Stockholders' Equity|Book Capitalization Treace Medical (TMCI)|Accounting Capitalization Strata Medical (SRTA)|Carlsmed Inc (CARL) - Company Net Assets|Accounting Value of Company RXST (rxsight.com)|ClearPoint Neuro - Company Book Value|Company Net Assets Stereotaxis Inc STXS|STIM (NeuroStar) - Book Capitalization|SGHT - Total Stockholders' Equity|Book Capitalization Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Accounting Capitalization|NSPR: Book Capitalization|Book Valuation of Business Jin Medical International Ltd|Book Capitalization VANI (Vivani Medical, Inc.)|Company Net Assets xtantmedical.com (XTNT)|Book Capitalization NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Book Capitalization|MYO - Company Book Value|Envoy Medical Inc. (COCH) - Company Book Value|Company Net Assets Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Accounting Value of Company|Book Capitalization SINT (Sintx Technologies Inc)|Total Stockholders' Equity TNON|LFWD: Company Book Value|Book Value of Business autonomix.com AMIX|Company Net Assets IVF (INVO Bioscience, Inc.)|Book Capitalization Bone Biologics Inc BBLG|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value